Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Plus Therapeutics Inc PSTV

Healthcare Biotechnology
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PSTV)

Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus' Management Team

GlobeNewswire 10 days ago

Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference

GlobeNewswire March 27, 2024

Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic

GlobeNewswire March 25, 2024

Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases

GlobeNewswire March 11, 2024

Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

GlobeNewswire March 5, 2024

Plus Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on March 5, 2024

GlobeNewswire February 27, 2024

Plus Updates Financial and Cash Guidance for 2024

GlobeNewswire December 18, 2023

Plus Therapeutics Partners With K2bio for Development of Novel Tests for Cerebrospinal Fluid (CSF) Tumor Cell and Molecular Biomarker Analyses

GlobeNewswire December 12, 2023

Plus Therapeutics to Present at the 5th Targeted Radiopharmaceuticals Summit Europe

GlobeNewswire November 29, 2023
View More News ››

Opinion & Analysis (NDAQ:PSTV)

Plus Therapeutics Shares Trade Higher on Q3 Earnings and Business Restructuring

Streetwise Reports November 18, 2019

What Stephen Hawking Missed: ...

Streetwise Reports May 2, 2018

Companies flocking to Japan for biotech deals

The Life Sciences Report February 2, 2017
View More Opinion ››

Bullboard Posts (NDAQ:PSTV)

Plus Therapeutics to Present at the 2nd Annual Targeted Radi

Just In: $PSTV Plus Therapeutics to Present at the 2nd Annual Targeted Radiopharmaceuticals SummitAUSTIN, Texas, July 13, 2023 (GLOBE...
whytestocks - July 13, 2023

Plus Therapeutics to Participate in the 2023 Healthcare Virt

BREAKING NEWS: $PSTV Plus Therapeutics to Participate in the 2023 Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted...
whytestocks - June 14, 2023

I guess there is t anyone talking about this stock

Crickets.  Well I like this stock!!  Join me!!
Chester55 - August 21, 2021

In some here....

Cheers !
Iseneschal - February 11, 2021

still holding this stock

used dollar cost averaging for it after getting caught by an upswing followed by a cheap stock financing,so glta shareholders but it...
coolfooldumbguy - December 16, 2019

it's a buy today for me

my last batch at these low prices,so glta shareholders.
coolfooldumbguy - September 25, 2019
View more Bullboard ››

Benchmark Metals Inc.

Benchmark Metals Inc.

Benchmark Metals Inc. is a Canada-based gold and silver company. The Company is primarily focused on the identification ...
View More »